- Investing Ideas
- Belgian Pharmaceuticals & Biotech Potentially Undervalued Companies
Belgian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
2
0 new
Companies with a Value score of at least 3, ordered by Value score
2 companies
UCB
Market Cap: €41.4b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€222.90
7D
-9.4%
1Y
20.6%
argenx
Market Cap: €46.7b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€745.00
7D
-7.4%
1Y
27.5%